Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rescigno

Showing results (571-580 of 1,117) with videos related to

Pageof 112
Sort By:
Life (Basel, Switzerland)|April 30, 2021
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern ItalyMariantonietta Pisaturo, Giulia De Angelis, Paolo Maggi, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
Cancers|June 2, 2021
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) PatientsRebeca Lozano, David Lorente, Isabel M Aragon, et al.
Scientific Reports|February 2, 2024
Association of vaccine status, reinfections, and risk factors with Long COVID syndromeMaria Elena Romero-Ibarguengoitia, Juan Francisco Rodríguez-Torres, Arnulfo Garza-Silva, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
Frontiers in Oncology|May 24, 2021
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort StudyCaterina Monari, Caterina Sagnelli, Paolo Maggi, et al.
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Frontiers in Bioscience (Elite Edition)|September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic ScoreGiulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.
European Urology Oncology|April 4, 2024
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 StudyFrancesco Massari, Veronica Mollica, Ondrej Fiala, et al.
NPJ Biofilms and Microbiomes|March 30, 2024
Microbial composition associated with biliary stents in patients undergoing pancreatic resection for cancerAitor Blanco-Míguez, Sara Carloni, Cindy Cardenas, et al.
Pageof 112

Showing results (571-580 of 1,117) with videos related to

Sort By:
Pageof 112
Life (Basel, Switzerland)|April 30, 2021
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern ItalyMariantonietta Pisaturo, Giulia De Angelis, Paolo Maggi, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
Cancers|June 2, 2021
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) PatientsRebeca Lozano, David Lorente, Isabel M Aragon, et al.
Scientific Reports|February 2, 2024
Association of vaccine status, reinfections, and risk factors with Long COVID syndromeMaria Elena Romero-Ibarguengoitia, Juan Francisco Rodríguez-Torres, Arnulfo Garza-Silva, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
Frontiers in Oncology|May 24, 2021
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort StudyCaterina Monari, Caterina Sagnelli, Paolo Maggi, et al.
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Frontiers in Bioscience (Elite Edition)|September 24, 2023
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic ScoreGiulia Mazzaschi, Alessandro Lazzarin, Matteo Santoni, et al.
European Urology Oncology|April 4, 2024
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 StudyFrancesco Massari, Veronica Mollica, Ondrej Fiala, et al.
NPJ Biofilms and Microbiomes|March 30, 2024
Microbial composition associated with biliary stents in patients undergoing pancreatic resection for cancerAitor Blanco-Míguez, Sara Carloni, Cindy Cardenas, et al.
Pageof 112